Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.8110
+0.0312 (4.00%)
At close: Mar 16, 2026, 4:00 PM EDT
0.8400
+0.0290 (3.58%)
Pre-market: Mar 17, 2026, 8:19 AM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $39.37 million as of March 17, 2026. Its market cap has decreased by -28.76% in one year.
Market Cap
39.37M
Enterprise Value
10.96M
1-Year Change
-28.76%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $39.37M, a decrease of -91.06%. That is a compound annual growth rate of -39.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 39.37M | 28.02% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 41.01M |
| Sensei Biotherapeutics | 40.73M |
| CervoMed | 39.35M |
| Veru Inc. | 38.36M |
| Chemomab Therapeutics | 37.87M |
| Tvardi Therapeutics | 36.77M |
| Celularity | 35.18M |
| INmune Bio | 34.83M |